209 related articles for article (PubMed ID: 12854891)
1. Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approach.
Eleutherakis-Papaiakovou V; Karali M; Kokkonouzis I; Tiliakos I; Dimopoulos MA
Leuk Lymphoma; 2003 Jun; 44(6):937-48. PubMed ID: 12854891
[TBL] [Abstract][Full Text] [Related]
2. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
Rajkumar SV; Witzig TE
Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
[TBL] [Abstract][Full Text] [Related]
3. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in multiple myeloma.
Rajkumar SV; Kyle RA
Semin Oncol; 2001 Dec; 28(6):560-4. PubMed ID: 11740809
[TBL] [Abstract][Full Text] [Related]
6. The importance of antiangiogenic effect in multiple myeloma treatment.
Barchnicka A; Olejniczak-Nowakowska M; Krupa-Kotara K; Grosicki S
Adv Clin Exp Med; 2018 Feb; 27(2):291-297. PubMed ID: 29521075
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow angiogenesis in multiple myeloma: new insights into the pathogenesis, and development of a new therapeutic approach].
Hattori Y; Kakimoto T
Rinsho Ketsueki; 2000 May; 41(5):426-9. PubMed ID: 10879105
[No Abstract] [Full Text] [Related]
8. Antiangiogenic therapy in hematologic malignancies.
Moehler TM; Hillengass J; Goldschmidt H; Ho AD
Curr Pharm Des; 2004; 10(11):1221-34. PubMed ID: 15078137
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.
Ribatti D; Vacca A; Nico B; Quondamatteo F; Ria R; Minischetti M; Marzullo A; Herken R; Roncali L; Dammacco F
Br J Cancer; 1999 Feb; 79(3-4):451-5. PubMed ID: 10027312
[TBL] [Abstract][Full Text] [Related]
10. Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.
Mileshkin L; Honemann D; Gambell P; Trivett M; Hayakawa Y; Smyth M; Beshay V; Ritchie D; Simmons P; Milner AD; Zeldis JB; Prince HM
Haematologica; 2007 Aug; 92(8):1075-82. PubMed ID: 17640854
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy in multiple myeloma.
Tosi P; Tura S
Acta Haematol; 2001; 106(4):208-13. PubMed ID: 11815718
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic switch in multiple myeloma.
Giuliani N; Colla S; Rizzoli V
Hematology; 2004; 9(5-6):377-81. PubMed ID: 15763977
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow angiogenesis in multiple myeloma: effect of therapy.
Kumar S; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Greipp PR; Rajkumar SV
Br J Haematol; 2002 Dec; 119(3):665-71. PubMed ID: 12437642
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of thalidomide in refractory multiple myeloma.
Singhal S; Mehta J; Desikan R; Ayers D; Roberson P; Eddlemon P; Munshi N; Anaissie E; Wilson C; Dhodapkar M; Zeddis J; Barlogie B
N Engl J Med; 1999 Nov; 341(21):1565-71. PubMed ID: 10564685
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis and endothelial cells in blood neoplasms].
Usnarska-Zubkiewicz L; Poreba M; Kuliczkowski K
Przegl Lek; 2006; 63(3):146-50. PubMed ID: 16969900
[TBL] [Abstract][Full Text] [Related]
16. New Insights in Anti-Angiogenesis in Multiple Myeloma.
Ribatti D; Vacca A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002349
[TBL] [Abstract][Full Text] [Related]
17. Current status of thalidomide in the treatment of cancer.
Rajkumar SV
Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization.
Schreiber S; Ackermann J; Obermair A; Kaufmann H; Urbauer E; Aletaha K; Gisslinger H; Chott A; Huber H; Drach J
Br J Haematol; 2000 Sep; 110(3):605-9. PubMed ID: 10997971
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in hematologic malignancies.
Moehler TM; Neben K; Ho AD; Goldschmidt H
Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies.
Vacca A; Ribatti D; Roncali L; Dammacco F
Leuk Lymphoma; 1995 Dec; 20(1-2):27-38. PubMed ID: 8750620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
